Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Nymox Pharmaceutical Corporation

Nymox Announces Dismissal of Delaware Action Against Ascella
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
NYMOX Announces Trading Resumed and New Listing on OTCQB Market
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox Announces Filing of Annual Report
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox Annual Report
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox Required to Resubmit Application to DKMA
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox December 27 Message to Shareholders
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox Reports Completion of $2 Million Private Placement
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox Announces $2 Million Private Placement
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox's 3-month ex-CFO was Awarded an Unauthorized and Undisclosed Treasury Directive for 100,000 Shares of Nymox Stock Without the Knowledge or Approval of the Nymox Board or Nymox’s CEO
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMXF
Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMX
Nymox Reports on U.S. Patent Issuances
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMX
Nymox Update
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMX
Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMX
NYMOX Update
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMX
Nymox Delisting from NASDAQ
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMX
Nymox Provides Current Update
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMX
Nymox Provides Corporate Update
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMX
Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMX
Nymox Officially Granted Extension to Regain Listing Requirements
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Tickers NYMX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.